Evidence Brief

Wearable Metabolic Evidence.

PI was applied to a Garmin-derived wearable and metabolic hybrid case centered on fasting blood glucose. This page summarizes what the latest artifact set supports, what PI demonstrated, and what it does not claim.

This brief reflects the latest audited Stage 3 wearable-metabolic artifact dated April 19, 2026. It is an evidence summary, not a clinical validation claim.

At a glance

What this evidence covers.

PI reviewed one within-person wearable and metabolic case rather than a population cohort. The run kept fasting glucose as the anchor target, used recovery and stress structure to explain the broader picture, and preserved clear boundaries between explanation, caution, and governed action.

186 Observed days

The latest case window ran from October 12, 2025 to April 15, 2026.

228 Confirmed edges

Stage 3 kept confirmed direct and interaction structure in view.

1,091 Confirmed chains

Pathway structure was preserved around the active gold targets.

1 SEM-confirmed focal link

The headline metabolic link was carried by the SEM lane.

What PI demonstrated

What the run shows clearly.

The value here is not a wellness score. It is that PI could hold onto a sparse metabolic story, show the wider recovery picture, and stay conservative when the action lane was not ready.

Sparse metabolic structure still held

PI kept Elevated Fasting Glucose Pattern as the anchor target even though glucose was comparatively sparse and the raw pairwise overlap did not support a simple direct rule.

Recovery strain explained the wider picture

The broader structure clustered around recovery reserve, under-recovery, stress, and sleep, rather than treating fasting glucose as an isolated metric.

Action stayed governed after selection

PI computed local candidate dose surfaces and still withheld recommendation-grade action on the focal metabolic target when cross-target impact stayed unresolved.

Current posture

What the current case looked like.

  • Single Episode Authority was preserved across the full window.
  • The anchor target was Elevated Fasting Glucose Pattern.
  • The main explanation was Low Sleep Recovery Pattern to Elevated Fasting Glucose Pattern.
  • The strongest caution-grade action lane was Lowest Recovery Reserve (Body Battery) to Morning Recovery Reserve (Body Battery).
  • No recommendation-grade intervention was released for the fasting glucose focus target.

Why this matters

This is exactly where PI needs to stay honest.

A sparse wearable-metabolic case is where many systems either say too little or say too much. PI instead kept the metabolic story in view, showed the broader recovery system around it, and stopped short of governed action when the evidence did not yet justify release.

Two output lanes

The same case produced explanation and action very differently.

This is one of the clearest parts of the artifact set. PI could keep a useful explanation and a useful caution lane without pretending they had the same authority.

Explanation lane

Fasting glucose stayed at the center.

Anchor target

186 Overlapping observations
525 Gold-target chains
1 SEM-confirmed focal link
  • The anchor target was Elevated Fasting Glucose Pattern.
  • The explanatory headline was Low Sleep Recovery Pattern to Elevated Fasting Glucose Pattern.
  • The raw pairwise overlap was weak and not simple enough for a direct improvement rule.
  • PI kept the finding because the SEM lane confirmed the persistent-state relationship.
  • The broader system center sat around Current Recovery Reserve (Body Battery) rather than glucose in isolation.
Governed action lane

Local dose planning did not become released guidance.

Intervention status

27 Candidates reviewed
3 Dose plans computed
0 Interventions released
  • The governed action lane ended in Gold Target Objective Not Satisfied.
  • No recommendation-grade item was released for the fasting glucose focus target.
  • Some local targets, including stress and Body Battery measures, were recommendation-eligible in isolation.
  • The top caution-grade signal was Lowest Recovery Reserve (Body Battery) to Morning Recovery Reserve (Body Battery).
  • This shows PI can surface usable context without pretending it has cleared governed action.

What PI kept in view

The artifact surfaced more than one headline.

Even with fasting glucose as the anchor target, PI kept showing the wider system that seemed to organize the case and the watch signals that could still reshape it.

Broader system center

Recovery reserve sat underneath the metabolic headline.

Current Recovery Reserve (Body Battery), along with under-recovery and average stress, repeatedly appeared as the deeper organizing structure behind the current picture.

Where pressure landed

Sleep and morning recovery kept taking the impact.

Across the current graph, the strongest landing points were Deep Sleep Time, Sleep Duration, and Morning Recovery Reserve.

Watch signals

The next checks still matter.

PI kept watch on fasting glucose at the upper edge of its target band, low deep sleep, elevated stress, and low recovery reserve because those signals could materially reshape the story.

Governance

What kept the brief honest.

  • Single-episode authority and freshness state were preserved.
  • Raw grounding stayed visible even when the direction was not simple.
  • SEM confirmation, reinforcement, and contradiction handling stayed explicit.
  • Explanation, actionable-with-caution, and recommendation lanes stayed separate.
  • Cross-target impact had to clear the gold-target objective before release.

Claim boundaries

What this page does not claim.

  • This is not a diagnosis or treatment recommendation page.
  • This is not a clinical validation claim.
  • This does not prove wearable-derived recovery proxies alone are enough for autonomous metabolic guidance.
  • This does not prove the SEM-confirmed metabolic link is intervention-grade.
  • This does not turn local MED or optimal dose surfaces into a released fasting-glucose recommendation.
  • One within-person case is not a population claim.

Discuss the evidence

Talk through the wearable-metabolic findings.

The best discussion is usually about fit and next evidence: what PI already demonstrated in this wearable-metabolic case, what remains gated, and what should improve in the next longitudinal run.